torsdag den 2 maj

Lifco: Sval byggsektor påverkar

Ludvig Löngårdh
Stockholmsbörsen
(), idag
-
-

NeuroVive Pharmaceutical
NeuroVive: Q1 on the right track (Redeye)

2020-05-20 09:01
NeuroVive reported results for Q1 with a loss of SEK 16.5m. It raised SEK 67m before issue cost and will be deciding on the SEK 20m direct issue to Hadean Ventures. The company has taken measures to minimise the impact of the covid-19 crisis of its projects. We think NeuroVive is on the right track.

info@redeye.se (Redeye.se)
Redeye AB - Redeye.se

Abliva - I dag

{point.key}

Senaste nytt

Visa alla telegram

Marknadsöversikt

Stockholmsbörsen, OMXS30

I dag
-
Senast
-
{point.key}

Världsindex
Index +/- % Senast
DAX - -
Hang Seng - -
Nikkei - -

Valutor
Valuta +/- % Senast
USD/SEK - -
EUR/SEK - -
GBP/SEK - -
EUR/USD - -

Räntor
Ränta +/- % Senast
5-års ränta - -
10-års ränta - -

Råvaror
Råvara +/- % Senast
Guld - -
Silver - -
Koppar - -